Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Beam Therapeutics Inc (BEAM)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Beam's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
25.70 -0.23    -0.89%
- Closed. Currency in USD ( Disclaimer )
Pre Market
25.67
-0.03
-0.12%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,796,670
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 25.14 - 26.42
Beam 25.70 -0.23 -0.89%

Beam Therapeutics Inc Company Profile

 
Get an in-depth profile of Beam Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

439

Equity Type

ORD

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; BEAM-201, an anti-CD7 CAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

Contact Information

Address 238 Main Street 9th Floor
Cambridge, 02142-1016
United States
Phone 857 327 8775
Fax -
Web beamtx.com

Top Executives

Name Age Since Title
John M. Evans 45 2017 CEO & Director
Christi L. Shaw 56 2023 Director
Carole Ho 51 2018 Independent Director
Kristina M. Burow 51 2017 Independent Director
Mark C. Fishman 73 2018 Independent Director
Graham K. Cooper 54 2019 Independent Director
John M. Maraganore 62 2021 Independent Director
Kathleen E. Walsh 67 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BEAM Comments

Write your thoughts about Beam Therapeutics Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Otis Grant
Otis Grant Feb 29, 2024 12:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
How do they need to dilute shares when thier revenue just beat by nearly 10X?
Reply
0 0
Report
Peter Chau
Peter Chau Feb 27, 2024 10:53AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
BEAM stock price was more than CRSP - has great potential. Ecause of better technology than CRSP
Reply
1 0
Report
Otis Grant
Otis Grant Feb 27, 2024 10:53AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I don't ever remember it being more than crsp in 3 years following
Reply
0 0
Report
jason xx
jason xx May 25, 2023 10:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There goes all of Beams gains
Reply
0 0
Report
jason xx
jason xx Apr 24, 2023 5:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What ever happened with the hold? We were supposed to get an update months ago.
Reply
1 0
Report
Kris Jay
Kris Jay Aug 01, 2022 9:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
the interesting thing to note is how BEAM after weeks of going up, went down late Friday afternoon prior announcement from FDA. This speaks volumes that there are leaks that are given to some and they benefit from those leaks. I was short as it is a ridiculous valuation given the negative earnings but Cathy Wood kept driving up the price.
Reply
0 1
Report
jason xx
jason xx Aug 01, 2022 9:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What fda announcement?
Reply
0 0
Report
Kris Jay
Kris Jay Aug 01, 2022 9:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
halted BEAM clinical trial on Monday morning. tell me the Paul Pelosi's of the world did not get a heads up on this on Friday.
Reply
0 0
Report
jason xx
jason xx Aug 01, 2022 9:16AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They definitely did. Ive seen similar things on plenty of other stuff
Reply
0 0
Report
Kris Jay
Kris Jay Jul 20, 2022 11:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The mystery of BEAM. The one agreement they have is with VERVE which just went down by 10%
Reply
0 0
Report
Kris Jay
Kris Jay Jul 20, 2022 11:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
sorry 14% in after hours trading.
Reply
0 0
Report
jason xx
jason xx Jul 20, 2022 11:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They have an agreement with Pfizer
Reply
0 0
Report
Kris Jay
Kris Jay Jul 20, 2022 11:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i know, and? their earnings are still negative since agreement signed in Dec and the agreement calls for certain milestones to be met in order to get paid.
Reply
0 0
Report
Kris Jay
Kris Jay Jul 20, 2022 11:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
great long term play but very pricey given where they are financially and Verve just doing trials (the one licensee).
Reply
0 0
Report
jason xx
jason xx Jul 20, 2022 11:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
And? Most clinical stage Bios have negative earnings. This was trading at 150 a share last year and if a positive catalyst comes out it will easily go over 100. Since when does every stock have to have a so called "fair" valuation?
Reply
0 0
Report
Kris Jay
Kris Jay Jul 20, 2022 9:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it defies logic. Cathy driving up the price artificially
Reply
0 0
Report
Kris Jay
Kris Jay Jul 08, 2022 11:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i dont understand what makes BEAM attractive at $50 valuations. $4B cap for a company with $60M in sales and -$400M in revenue. What am I missing that causes this stock to go up when companies with revnue and earnings are going down?
Reply
0 0
Report
jason xx
jason xx Jul 08, 2022 11:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
cas12
Reply
0 0
Report
Kris Jay
Kris Jay Jul 08, 2022 11:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
in English please?
Reply
0 0
Report
Jorge Diaz
Jorge Diaz Jul 16, 2021 1:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ok, i enter in 90.05🚀🚀🚀
Reply
1 0
Report
Ray Weber
Ray Weber Jul 16, 2021 1:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hang on to this and build off the Bio Tech. Today is your lucky day. I am about to share some very valuable info with you. Use it wisely!! Its going to make you rich. Y am i telling you and only you?? Lol. I want to!! Use it wisely!! CSPR, EDIT,BEAM,BNGO,PACB… That is the FUTURE, not EVs. Its about Health. Making vaccines, ending bio threat. Its immediate. Good luck bud. Read up on this. You will be good
Reply
3 0
Report
Eren Eren
Eren Eren Jul 16, 2021 1:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ray Weber it all crashed
Reply
0 0
Report
Eren Eren
Eren Eren Jul 16, 2021 1:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Did you hold?
Reply
0 0
Report
Ray Weber
Ray Weber Jun 28, 2021 7:22AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Fly zone!! Bio tech
Reply
3 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email